AAAAAA

   
Results: 1-9 |
Results: 9
Pharmacokinetic and pharmacodynamic properties of antimicrobials in the therapy of respiratory tract infections
Authors: Andes, D
Citation: D. Andes, Pharmacokinetic and pharmacodynamic properties of antimicrobials in the therapy of respiratory tract infections, CURR OPIN I, 14(2), 2001, pp. 165-172
Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model
Authors: Andes, D Stamsted, T Conklin, R
Citation: D. Andes et al., Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model, ANTIM AG CH, 45(3), 2001, pp. 922-926
Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint
Authors: Drusano, GL Preston, SL Hardalo, C Hare, R Banfield, C Andes, D Vesga, O Craig, WA
Citation: Gl. Drusano et al., Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint, ANTIM AG CH, 45(1), 2001, pp. 13-22
Report of a successful prolonged antifungal therapy for refractory allergic fungal sinusitis
Authors: Andes, D Proctor, R Bush, RK Pasic, TR
Citation: D. Andes et al., Report of a successful prolonged antifungal therapy for refractory allergic fungal sinusitis, CLIN INF D, 31(1), 2000, pp. 202-204
In vivo characterization of the pharmacodynamics of flucytosine in a neutropenic murine disseminated candidiasis model
Authors: Andes, D van Ogtrop, M
Citation: D. Andes et M. Van Ogtrop, In vivo characterization of the pharmacodynamics of flucytosine in a neutropenic murine disseminated candidiasis model, ANTIM AG CH, 44(4), 2000, pp. 938-942
In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria
Authors: van Ogtrop, ML Andes, D Stamstad, TJ Conklin, B Weiss, WJ Craig, WA Vesga, O
Citation: Ml. Van Ogtrop et al., In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria, ANTIM AG CH, 44(4), 2000, pp. 943-949
Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model
Authors: Andes, D van Ogtrop, H
Citation: D. Andes et H. Van Ogtrop, Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model, ANTIM AG CH, 43(9), 1999, pp. 2116-2120
Use of pharmacodynamic indices to predict efficacy of combination therapy in vivo
Authors: Mouton, JW van Ogtrop, LL Andes, D Craig, WA
Citation: Jw. Mouton et al., Use of pharmacodynamic indices to predict efficacy of combination therapy in vivo, ANTIM AG CH, 43(10), 1999, pp. 2473-2478
Pharmacokinetics and pharmacodynamics of outpatient intravenous antimicrobial therapy
Authors: Andes, D Craig, WA
Citation: D. Andes et Wa. Craig, Pharmacokinetics and pharmacodynamics of outpatient intravenous antimicrobial therapy, INF DIS CL, 12(4), 1998, pp. 849
Risultati: 1-9 |